Podchaser Logo
Home
113: After slow IPO, Gland Pharma finds more takers in secondary markets

113: After slow IPO, Gland Pharma finds more takers in secondary markets

Released Thursday, 26th November 2020
Good episode? Give it some love!
113: After slow IPO, Gland Pharma finds more takers in secondary markets

113: After slow IPO, Gland Pharma finds more takers in secondary markets

113: After slow IPO, Gland Pharma finds more takers in secondary markets

113: After slow IPO, Gland Pharma finds more takers in secondary markets

Thursday, 26th November 2020
Good episode? Give it some love!
Rate Episode

Unlock Episode Insights with

Podchaser Logo PRO

Reach • Demographics • Contacts • More

Pro Features

Audience & Reach for 113: After slow IPO, Gland Pharma finds more takers in secondary markets

See a breakdown of Audience & Reach for 113: After slow IPO, Gland Pharma finds more takers in secondary markets

Unlock Episode Audience & Reach with Podchaser Pro

Brand Safety for 113: After slow IPO, Gland Pharma finds more takers in secondary markets

See Brand Safety for 113: After slow IPO, Gland Pharma finds more takers in secondary markets

Unlock Episode Brand Safety with Podchaser Pro

Ad Rate Card of Mark to Market

How much does it cost to advertise on Mark to Market?

PlacementCost
Pre-rollAds played before an episode.
Mid-rollAds played during an episode.
Post-rollAds played after an episode.

Frequently Asked Questions about Mark to Market

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features